New Issue: Orbital Catastrophe Ahead? Read Now

Inhaled RNA Might Help Heal Cystic Fibrosis

Scientists are working to correct a genetic defect in cystic fibrosis patients by having them inhale RNA. Christopher Intagliata reports.

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!

Your genome is sort of like a library—with each gene an instruction manual for making proteins. Bad news is, you can’t return a book and take out a new edition. But the technique of gene therapy allows you to revise your copy of the book, so to speak…giving you the ability, potentially, to make new and different proteins.

Now scientists have experimented with a new way to make text revisions—by inhaling the changes. They tested the concept by having mice breathe in genetic material called messenger RNA, or mRNA. For the test, the mRNA included instructions to manufacture luciferase—the stuff that lights up in fireflies. 

The researchers packaged the mRNA with a degradable polymer, to trick the mice's lung cells into accepting the package. And once the cells gobbled it up, they began to glow—proving that inhaling mRNA is an effective way to kick-start the production of new and novel proteins, like the firefly enzyme. 


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


The scientists also repeated the experiment in mice whose cells had been genetically engineered to turn permanently red if they received a copy of mRNA—making it possible to count the proportion of cells affected by a dose. The proof of concept is in the journal Advanced Materials. [Asha Kumari Patel et al., Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium]

Of course, the point isn't to make mice glow. Instead, one idea is to use this technique to help cystic fibrosis patients. People with CF have a genetic mutation that causes a buildup of sticky mucus in their lungs. Several of the study authors work with a publicly traded biotech company called Translate Bio, which is conducting phase 1 and 2 trials to determine if inhaling messenger RNA could provide a genetic fix for cystic fibrosis. Regardless of the particular case of CF, the luciferase example shows that inhalation genetic therapy could be an inspiration. 

—Christopher Intagliata

[The above text is a transcript of this podcast.]

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe